Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference

Reuters
2025.12.04 14:05
portai
I'm PortAI, I can summarize articles.

Dec 4 (Reuters) - Edwards Lifesciences Corp:EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCEREAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62PROJECTS 2026 SALES GROWTH OF 8%-10%OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION – LSEG IBES DATAFY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION – LSEG IBES DATA Source text: Further company coverage:

Dec 4 (Reuters) - Edwards Lifesciences Corp (EW.N) :

  • EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCE
  • REAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%
  • REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62
  • PROJECTS 2026 SALES GROWTH OF 8%-10%
  • OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95
  • FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION – LSEG IBES DATA
  • FY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION – LSEG IBES DATA Source text: Further company coverage: (EW.N)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer